Gene · 6091
Papers2,184
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,184
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Challenges and new technologies in adoptive cell therapy. | J Hematol Oncol | 2023 | 37596653 | PubTator, text mining | PubMed |
| Applications of nanotechnologies for miRNA-based cancer therapeutics: current advances and future perspectives. | Front Bioeng Biotechnol | 2023 | 37576994 | PubTator, text mining | PubMed |
| Chimeric antigen receptor engineered natural killer cells for cancer therapy. | Exp Hematol Oncol | 2023 | 37563648 | PubTator, text mining | PubMed |
| Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. | Genes Dis | 2023 | 37554181 | PubTator, text mining | PubMed |
| Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. | Front Immunol | 2023 | 37539051 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| Systematic analysis of the Frazzled receptor interactome establishes previously unreported regulators of axon guidance. | Development | 2023 | 37526651 | PubTator, text mining | PubMed |
| In silico analysis of serum miRNA profiles in seronegative and seropositive rheumatoid arthritis patients by small RNA sequencing. | PeerJ | 2023 | 37525657 | PubTator, text mining | PubMed |
| Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis. | Acta Neuropathol Commun | 2023 | 37525259 | PubTator, text mining | PubMed |
| Recent advances of exosomal circRNAs in cancer and their potential clinical applications. | J Transl Med | 2023 | 37525158 | PubTator, text mining | PubMed |
| Time-Course of Transcriptomic Change in the Lungs of F344 Rats Repeatedly Exposed to a Multiwalled Carbon Nanotube in a 2-Year Test. | Nanomaterials (Basel) | 2023 | 37513116 | PubTator, text mining | PubMed |
| Genome-Wide Epistasis Study of Cerebrospinal Fluid Hyperphosphorylated Tau in ADNI Cohort. | Genes (Basel) | 2023 | 37510227 | PubTator, text mining | PubMed |
| TempShift Reveals the Sequential Development of Human Neocortex and Skewed Developmental Timing of Down Syndrome Brains. | Brain Sci | 2023 | 37509002 | PubTator, text mining | PubMed |
| Role of the SLIT-ROBO signaling pathway in renal pathophysiology and various renal diseases. | Front Physiol | 2023 | 37497439 | PubTator, text mining | PubMed |
| The Role of Neural and Genetic Processes in Learning to Read and Specific Reading Disabilities: Implications for Instruction. | Read Res Q | 2023 | 37456924 | PubTator, text mining | PubMed |
| Epigenetic modification in diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | 37455912 | PubTator, text mining | PubMed |
| Repression of Smad3 by silencing Robo1 attenuates epithelial-mesenchymal transition in tracheobronchial stenosis. | Chin Med J (Engl) | 2023 | 37455334 | PubTator, text mining | PubMed |
| Genetic insight into the putative causal proteins and druggable targets of osteoporosis: a large-scale proteome-wide mendelian randomization study. | Front Genet | 2023 | 37448626 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors. | Cancers (Basel) | 2023 | 37444642 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6091/papers?page=10